Skip to main content
Log in

Inhibition of B16BL6 melanoma invasion by tyrosine and phenylalanine deprivation is associated with decreased secretion of plasminogen activators and increased plasminogen activator inhibitors

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

We previously found that dietary tyrosine (Tyr) and phenylalanine (Phe) limitation significantly decreased the metastatic phenotype of B16BL6 melanoma cells in vivo and decreased the in vitro invasion of these cells. To more specifically characterize the effects of Tyr and Phe deprivation we examined the three steps involved in invasion: attachment to host cells and components, elaboration of proteases that degrade basement membranes, and migration of invading tumor cells. Here we report that B16BL6 melanoma cell invasion through growth factor reduced (GFR) MatrigelTM is significantly decreased by Tyr and Phe deprivation. Tyr and Phe deprivation in vitro decreased the attachment of B16BL6 melanoma cells to GFR MatrigelTM, heparin sulfate proteoglycans (HSPG), neonatal murine epidermal (NME) cells and the extracellular matrix (ECM) from these cells. These cells also exhibited a decrease in chemotactic response to fetal bovine serum (FBS). Deprivation of these two amino acids decreased the secretion of urokinase plasminogen activator (uPA) and tissue plasminogen activator (tPA) while plasminogen activator inhibitor (PAI)-1 and -2 were increased in these cells. These observations suggest that Tyr and Phe deprivation decreases the in vitro chemotactic and invasive ability of B16BL6 melanoma cells by decreasing attachment and secreted PA activity and by increasing secreted PAIs in these cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rigel DS, Friedman RJ, Robinson JK, Amonette RA. Melanoma Incidence: If it quacks like a duck. Arch Dermatol 1997; 133: 656–9.

    Article  PubMed  CAS  Google Scholar 

  2. Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv 1994; 19: 219–40.

    PubMed  Google Scholar 

  3. Abdallah RM, Starkey JR, Meadows GG. Dietary restriction of tyrosine and phenylalanine: Inhibition of metastasis of three rodent tumors. J Natl Cancer Inst 1987; 78: 759–66.

    PubMed  CAS  Google Scholar 

  4. Elstad CA, Meadows GG, Abdallah RM. Specificity of the suppression of metastatic phenotype by tyrosine and phenylalanine restriction. Clin Exp Met 1990; 8: 393–416.

    Article  CAS  Google Scholar 

  5. Uhlenkott CE, Huijzer JC, Cardeiro DJ, Elstad CA, Meadows GG. Attachment, invasion, chemotaxis, and proteinase expression of B16-BL6 melanoma cells exhibiting a low metastatic phenotype after exposure to dietary restriction of tyrosine and phenylalanine. Clin Expl Met 1996; 14: 125–37.

    Article  CAS  Google Scholar 

  6. Taipale J, Keski-oja J. Growth factors in the extracellular matrix. FASEB J 1997; 11: 51–9.

    PubMed  CAS  Google Scholar 

  7. Hearing VJ, Law LW, Corti A et al. Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. Cancer Res 1988; 48: 1270–8.

    PubMed  CAS  Google Scholar 

  8. Jalkanen M. Biology of cell surface heparan sulfate proteoglycans. Med Biol 1987; 65: 41–7.

    PubMed  CAS  Google Scholar 

  9. Salmivirta M, Lidholt K, Lindahl U. Heparan sulfate: A piece of information. FASEB J 1996; 10: 1270–9.

    PubMed  CAS  Google Scholar 

  10. Mathiak M, Yenisey C, Grant DS et al. A role for perlecan in the supression of growth and invasion in fibrosarcoma cells. Cancer Res 1997; 57: 2130–6.

    PubMed  CAS  Google Scholar 

  11. Kwaan HC. The plasminogen-plasmin system in malignancy. Cancer Met Rev 1992; 11: 291–311.

    Article  CAS  Google Scholar 

  12. Eisinger M, Marko O, Ogata S-I. Growth regulation of human melanocytes: Mitogenic factors in extracts of melanoma, astrocytoma, and fibroblast cell lines. Science 1985; 229: 984–6.

    PubMed  CAS  Google Scholar 

  13. Bachmann F. The enigma PAI-2. gene expression, evolutionary and functional aspects. Thromb Haemostas 1995; 74: 172–9.

    CAS  Google Scholar 

  14. Hart IR. The selection and characterization of an invasive variant of the B16 melanoma. Am J Pathol 1979; 97: 587–600.

    PubMed  CAS  Google Scholar 

  15. Fu Y-M, Yu Z-X, Pelayo BA et al. Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency. Cancer Res 1999; 59: 758–765.

    PubMed  CAS  Google Scholar 

  16. Elstad CA, Meadows GG. Modulation of B16-BL6 murine melanoma metastatic phenotype by tyrosine and phenylalanine restriction in the absence of host selection pressures. Anticancer Res 1993; 13: 523–8.

    PubMed  CAS  Google Scholar 

  17. Hendrix MJC, Seftor EA, Seftor REB, Fidler IJ. A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett 1987; 38: 137–47.

    Article  PubMed  CAS  Google Scholar 

  18. Falk W, Goodwin Jr RH, Leonard EJ. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Meth 1980; 33: 239–47.

    Article  CAS  Google Scholar 

  19. Fridman R, Scott AF, Muller D et al. The role of cell adhesion and migration in the in vitro invasiveness of mouse adrenal carcinoma cells. Invasion Met 1990; 10: 208–24.

    CAS  Google Scholar 

  20. Edward B, Luikart SD, Long MW, Hoffman R. Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoetic progenitor cells to cytokines. Exp Hematol 1995; 23: 1212–17.

    Google Scholar 

  21. Elstad CA, Hosick HL. Contribution of the extracellular matrix to growth properties from a preneoplastic outgrowth: Possible role of hyaluronic acid. Expl Cell Biol 1987; 55: 313–21.

    Article  CAS  Google Scholar 

  22. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980; 102: 196–202.

    Article  PubMed  CAS  Google Scholar 

  23. Biro S, Fu Y-M, Yu Z-X, Epstein SE. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle proliferation and migration. Proc Natl Acad Sci 1993; 90: 654–8.

    Article  PubMed  CAS  Google Scholar 

  24. Fu Y-M, Yu Z-X, Ferrans VJ, Meadows GG. Tyrosine and phenylalanine restriction induces G0/G1 cell cycle arrest in murine melanoma in vitro and in vivo. Nutr Cancer 1997; 29: 104–13.

    Article  PubMed  CAS  Google Scholar 

  25. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541–73.

    Article  PubMed  CAS  Google Scholar 

  26. Stetler-Stevenson WG, Corcoran ML. Tumor angiogenesis: functional similarities with tumor invasion. EXS 1997; 413–8.

  27. Edward M, MacKie RM. Cell-cell and cell-extracellular matrix interactions during melanoma cell invasion and metastasis. Melanoma Res 1993; 3: 227–34.

    PubMed  CAS  Google Scholar 

  28. Iozzo RV. Perlecan: a gem of a protoeglycan. Matrix Biol 1994; 14: 203–8.

    Article  PubMed  CAS  Google Scholar 

  29. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327–36.

    Article  PubMed  CAS  Google Scholar 

  30. Kawano T, Morimoto K, Uemura Y. Urokinase inhibitor in human placenta. Nature 1968; 217: 253-4.

    Article  PubMed  CAS  Google Scholar 

  31. Albini A, Iwamoto Y, Kleinman HK et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239–45.

    PubMed  CAS  Google Scholar 

  32. Kramer RH, Bensch KG, Wong J. Invasion of reconstituted basement membrane matrix by metastatic human tumor cells. Cancer Res 1986; 46: 1980–89.

    PubMed  Google Scholar 

  33. Meadows GG, Pierson HF, Abdallah RM, Desai PR. Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy. Cancer Res 1982; 42: 3056–63.

    PubMed  CAS  Google Scholar 

  34. Schatzkin A. Dietary change as a strategy for preventing cancer. Cancer Met Rev 1997; 16: 377–92.

    Article  CAS  Google Scholar 

  35. Martinez ME, Giovannucci E. Diet and the prevention of cancer. Cancer Met Rev 1997; 16: 357–76.

    Article  CAS  Google Scholar 

  36. Lester BR, McCarthy JB, Sun Z, Smith RS, Furcht LT, Spiegel AM. G-protein involvement in matrix-mediated motility and invasion of high and low experimental metastatic B16 melanoma clones. Cancer Res 1989; 49: 5940–8.

    PubMed  CAS  Google Scholar 

  37. Liotta LA. Tumor invasion and metastases-role of the extracellular matrix. Cancer Res 1986; 46: 1–7.

    Article  PubMed  CAS  Google Scholar 

  38. Reich R, Thompson EW, Iwamoto Y et al. Effects of inhibitors of plasminogen activator, serine proteases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 1988; 48: 3307–12.

    PubMed  CAS  Google Scholar 

  39. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992; 14: 455–63.

    Article  PubMed  CAS  Google Scholar 

  40. Kruithof EKO. Plasminogen activator inhibitors-a review. Enzyme 1988; 40: 113–21.

    PubMed  CAS  Google Scholar 

  41. Seftor REB, Seftor EA, Gehlsen KR et al. Role of the ?v?3 integrin in human melanoma cell invasion. Proc Natl Acad Sci 1992; 89: 1557–61

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pelayo, B.A., Fu, YM. & Meadows, G.G. Inhibition of B16BL6 melanoma invasion by tyrosine and phenylalanine deprivation is associated with decreased secretion of plasminogen activators and increased plasminogen activator inhibitors. Clin Exp Metastasis 17, 841–848 (1999). https://doi.org/10.1023/A:1006713000684

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006713000684

Navigation